PatternsRadar
Sign in

SUVENSuven Life Sciences Limited

NSE
Full chart
309.15INR+2.85 (+0.93%)Close · 6 Oct 2026
6 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹8,735 CrMarket cap
—P/E (TTM)
55.5%Delivery

Filings & corporate actions

79 results filed
CSV
Next results · Q2 FY27
Expected 26 Oct 2026 – 11 Nov 2026
Estimate: filed 26–42 days after quarter end, last 5 times
Dividend
₹1.50 per share · last 14 Feb 2019
2026
  • 6 AugresultsResults · Q1 FY27 · consolidated and standalone-2.7%NSE
  • 20 JulshareholdingShareholding · 8 Jul 2026+3.9%NSE
  • 16 JulshareholdingShareholding · 30 Jun 2026-4.2%NSE
  • 13 MayresultsResults · Q4 FY26 · consolidated and standalone-1.5%NSE
  • 16 AprshareholdingShareholding · 31 Mar 2026+2.1%NSE
  • 13 MarshareholdingShareholding · 6 Mar 2026+0.7%NSE
  • 29 JanresultsResults · Q3 FY26 · consolidated and standalone-0.6%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-0.7%NSE

Reaction to results · all yearsrose on day 0 in 39 of 78 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY276 Aug 2026-2.7%0.0%+15.9%0.8×
Q4 FY2613 May 2026-1.5%+28.5%+27.9%0.8×
Q3 FY2629 Jan 2026-0.6%+29.0%+13.5%0.7×
Q2 FY2611 Nov 2025-2.6%-4.6%-10.2%1.0×
Q1 FY2613 Aug 2025+1.3%-0.6%-2.8%1.1×
Q4 FY2513 May 2025+7.5%+23.6%+44.2%6.6×
Q3 FY2524 Jan 2025-4.2%+7.3%-2.9%0.6×
Q2 FY2529 Oct 2024+5.3%+13.7%+10.1%1.5×
Q1 FY255 Aug 2024-4.7%-7.4%+8.4%0.6×
Q4 FY247 May 2024-5.0%-10.3%-21.9%0.9×
Q3 FY2430 Jan 2024-3.2%+5.0%-9.2%0.2×
Q2 FY244 Nov 2023+4.0%+10.5%+7.9%1.1×
Q1 FY248 Aug 2023+1.7%-0.5%-0.2%3.7×
Q4 FY2310 May 2023+0.4%-0.9%+1.6%0.5×
Q3 FY233 Feb 2023-1.7%-1.0%-6.3%1.2×
Q2 FY2311 Nov 2022+0.6%+1.5%+3.1%0.4×
Q1 FY2326 Jul 2022+1.2%+3.0%+1.4%0.9×
Q4 FY227 May 2022-3.0%+0.7%-6.8%0.5×
Q3 FY221 Feb 2022-0.4%-1.7%-12.0%0.3×
Q2 FY2226 Oct 2021+3.4%+5.7%-3.6%0.4×
Q1 FY2210 Aug 2021-6.6%-0.4%-0.4%1.4×
Q4 FY215 May 2021-3.1%-1.7%-4.8%0.8×
Q3 FY2128 Jan 2021-1.4%+14.8%+18.0%0.5×
Q2 FY2128 Oct 2020-2.4%-6.4%-4.6%0.5×
Q1 FY2112 Aug 2020-6.2%-1.7%-9.7%1.5×
Q4 FY206 Jun 2020-2.3%-9.6%+13.8%1.2×
Q3 FY2014 Feb 2020+5.0%+33.7%-16.0%2.7×
Q2 FY2014 Nov 2019-3.0%-2.6%-13.5%5.6×
Q1 FY2015 Aug 2019+0.8%+10.5%+22.5%0.7×
Q4 FY1925 May 2019+1.8%+1.6%+1.9%1.6×
Q3 FY191 Mar 2019+3.0%+6.2%+3.7%1.2×
Q2 FY1922 Nov 2018-1.5%-5.5%-11.8%0.5×
Q1 FY195 Sept 2018+4.3%+17.8%-6.2%0.7×
Q4 FY1826 May 2018+3.0%-3.2%+12.8%0.9×
Q3 FY1810 Feb 2018+2.4%-1.7%-9.3%0.4×
Q2 FY1822 Nov 2017+0.8%-1.4%-6.5%1.0×
Q1 FY181 Sept 2017+0.3%-3.1%+8.2%0.7×
Q4 FY1726 May 2017+6.2%+6.2%-2.0%1.9×
Q3 FY172 Feb 2017+1.0%+3.8%-3.0%0.8×
Q2 FY1728 Nov 2016-0.2%+2.7%-8.2%0.7×
Q1 FY1721 Sept 2016+0.4%+1.2%+5.5%0.5×
Q4 FY1630 May 2016-0.8%-2.2%-6.7%0.6×
Q3 FY1613 Feb 2016+0.5%-14.3%+16.9%3.8×
Q2 FY1610 Nov 2015+1.6%-1.6%-5.4%2.4×
Q1 FY1616 Aug 2015-3.2%-14.2%-10.2%1.6×
Q4 FY1528 May 2015+2.8%-8.2%-10.3%0.9×
Q3 FY1510 Feb 2015-3.1%+4.3%+4.8%1.2×
Q2 FY1522 Nov 2014-0.2%-0.4%+5.6%0.3×
Q1 FY1521 Aug 2014+1.6%+26.4%+55.1%1.3×
Q4 FY1427 May 2014+4.0%+9.7%+17.8%0.7×
Q3 FY145 Feb 2014-1.7%-6.8%-4.1%1.1×
Q2 FY1418 Nov 2013+8.5%+4.8%+6.9%2.9×
Q1 FY1419 Aug 2013+5.6%+9.7%+44.2%1.2×
Q4 FY1320 May 2013-2.6%-9.4%-11.8%0.5×
Q3 FY1312 Feb 2013+4.9%-2.2%-3.2%3.0×
Q2 FY1316 Nov 2012-6.2%-12.7%+8.9%0.7×
Q1 FY1314 Aug 2012+9.6%+29.1%+48.0%8.0×
Q4 FY127 May 2012-3.9%-9.0%-11.0%1.0×
Q3 FY1231 Jan 2012-0.6%+3.5%-7.3%2.2×
Q2 FY121 Nov 2011+0.3%-5.0%-12.6%5.4×
Q1 FY1218 Aug 2011+0.9%-2.6%-0.9%2.5×
Q4 FY1130 May 2011-0.9%+1.6%-8.9%0.7×
Q3 FY1131 Jan 2011-1.2%-6.0%-12.7%1.8×
Q2 FY1127 Oct 2010-1.0%-6.2%-10.9%1.4×
Q1 FY1127 Jul 2010-2.3%-3.1%-3.5%2.3×
Q4 FY1030 Apr 2010+5.0%-6.1%-15.2%1.5×
Q3 FY1027 Jan 2010-5.7%-3.5%-13.3%1.1×
Q2 FY1031 Oct 2009-4.5%-0.2%+3.4%0.8×
Q1 FY1028 Jul 2009-3.8%-5.6%+47.6%2.4×
Q4 FY0929 Apr 2009+0.7%+17.2%+73.1%0.4×
Q3 FY0919 Jan 2009+3.2%-0.7%-13.2%4.3×
Q2 FY0931 Oct 2008+20.0%+20.0%+12.3%4.6×
Q1 FY0925 Jul 2008+1.7%+9.3%-2.3%2.1×
Q4 FY0826 Apr 2008-4.4%-1.7%-2.9%0.6×
Q3 FY0828 Jan 2008-3.0%+4.7%-5.7%0.5×
Q2 FY0830 Oct 2007+4.0%-0.3%+6.0%3.0×
Q1 FY0810 Aug 2007+0.5%-4.4%-7.7%1.2×
Q4 FY0726 Apr 2007-0.1%-7.6%-14.3%2.6×
Average+0.3%+2.2%+2.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+91.0%
Profit YoY—
Interest cost YoY+2597.4%
Revenue QoQ+134.6%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue-0.5%-13.9%-9.9%-8.9%-44.0%—
Profit——————

Key data

CSV
Open308.00
Day range302.30 – 312.50
52-week range124.11 – 403.35
From 52w high-23.4%
RSI (14)35.4
ATR (14)15.24
Volume9.20L
Avg volume (20D)5.09L
Rel volume1.81×
Volatility (1Y)56.9%
Turnover₹28.4Cr
SMA 50 / 200340.51 / 238.61

Delivery percentage

Latest · 6 Oct 202655.5%
20-day avg47.7%
1-year avg45.0%
Percentile (own history)62nd
Range7.4–100.0%
Sessions1,731

Over the last 20 sessions SUVEN settled 47.7% of its traded quantity, which is above average for an NSE equity. Its one-year average is 45.0%, so recent sessions are running 2.7 points higher than usual. The latest session ranks higher than 62% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHealthcare Research Analytics & Technology
PeersAPOLLOHOSPMAXHEALTHFORTISYATHARTHASTERDMMANIPALHOS

Performance returns

CSV
1D1W1M3M6M1Y
Price+0.93%-3.89%-18.29%-3.19%+95.71%+47.88%

Valuation

CSV
Market cap₹8,735 Cr
P/E (TTM)—
EPS (TTM)-12.47
Shares outstanding26.40Cr
Listed23 Oct 2003

Ownership

CSV
Promoter65.47%
Promoter Δ QoQ-4.61 pp
Public34.53%
FII0.48%
DII2.73%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)0.92.81.53.6
YoY chg-64.3%+74.5%+3.6%+91.0%
Net profit (₹ Cr)(77.3)(101.9)(45.6)(127.6)
YoY chg————
Net margin-8410.6%-3628.8%-2999.5%-3578.7%
EPS-3.48-4.55-2.02-4.84

Shareholding over time

CSV

By quarter

8 Jul 2026 · promoter 65.47% · public 34.53%
30 Sept 2021: promoter 60.00%31 Dec 2021: promoter 60.00%28 Mar 2022: promoter 64.98%31 Mar 2022: promoter 64.98%30 Jun 2022: promoter 64.98%30 Sept 2022: promoter 64.98%16 Nov 2022: promoter 64.98%31 Dec 2022: promoter 69.57%31 Mar 2023: promoter 69.57%30 Jun 2023: promoter 69.57%30 Sept 2023: promoter 69.57%31 Dec 2023: promoter 69.57%31 Mar 2024: promoter 69.57%30 Jun 2024: promoter 70.27%30 Sept 2024: promoter 70.27%31 Dec 2024: promoter 70.27%31 Mar 2025: promoter 70.27%30 Jun 2025: promoter 70.27%16 Jul 2025: promoter 67.43%30 Sept 2025: promoter 67.36%31 Dec 2025: promoter 67.36%6 Mar 2026: promoter 70.15%31 Mar 2026: promoter 70.15%30 Jun 2026: promoter 70.08%8 Jul 2026: promoter 65.47%
2021-092026-07
  • Promoter
  • Public and others
Promoter
65.47%
Public
34.53%
Promoter change
-4.61 pp
Filed
20 Jul 2026
FII
0.48%
DII
2.73%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25AQ4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue from operations3.12.52.41.02.61.61.51.90.92.81.53.6
Other income5.16.14.34.04.01.61.20.63.82.86.87.5
Total income8.28.56.75.06.63.22.72.54.75.68.311.1
Total expenses28.350.334.233.156.342.446.654.082.0107.553.9138.7
└ Finance costs0.00.00.00.00.00.00.00.00.00.00.20.5
└ Depreciation1.71.61.51.51.51.51.31.41.31.31.62.2
Profit before tax(12.7)(41.8)(27.5)(28.0)(49.6)(39.1)(43.9)(51.5)(77.3)(101.9)(45.6)(127.6)
Tax expense0.00.0(1.0)0.00.00.00.00.00.00.00.00.0
Net profit(12.7)(41.8)(26.5)(28.0)(49.6)(39.1)(43.9)(51.5)(77.3)(101.9)(45.6)(127.6)
EPS-0.58-1.92-1.22-1.29-2.27-1.79-2.02-2.36-3.48-4.55-2.02-4.84
Net margin-414.44%-1704.13%-1112.72%-2787.25%-1929.49%-2429.75%-2995.56%-2759.78%-8410.56%-3628.79%-2999.51%-3578.73%
PBT margin-414.44%-1704.13%-1154.75%-2787.25%-1929.49%-2429.75%-2995.56%-2759.78%-8410.56%-3628.79%-2999.51%-3578.73%
Tax rate————————————

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 6 Aug 2026.

SUVEN at a glance

  • SUVEN closed at ₹309.15 on 6 Oct 2026, +0.93% on the day, +47.9% over one year, 23.4% below its 52-week high of ₹403.35.
  • Delivery was 55.5% of traded quantity on 6 Oct 2026, the 62nd percentile of its own 1,731 sessions with a reading (20-session average 47.7%, 1-year average 45.0%).
  • Market capitalisation is ₹8,735 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-12.47).
  • Q1 FY27 results (consolidated, filed 6 Aug 2026): revenue ₹4 crore (+91.0% year on year), net profit ₹-128 crore; the price moved -2.7% on the first session after.
  • Promoters held 65.47% at 8 Jul 2026, down 4.61 percentage points on the previous filing.
  • Q2 FY27 results are expected between 26 Oct 2026 and 11 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHealthcare Research Analytics & Technology
ISININE495B01038
SeriesEQ
Listed23 Oct 2003
History from24 Oct 2003
Sessions5,696
Turnover rank#842

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE